Bitcoin’s reclaim of the $84,000 support zone now hinges on Treasury yields, fresh inflation data, and stronger ETF demand.
Eli Lilly and Co. revealed new analysis data indicating that its medications, Zepbound and Foundayo, yielded superior weight loss and blood sugar control compared to competing Novo Nordisk A/S ...
A research team at the University of Vienna, led by pharmaceutical chemist Johannes Kirchmair, has developed a statistical ...
Qure (QURE) stock crashed 48% after AMT-130 Huntington's disease gene therapy missed statistical targets in 48-month trial ...
Qure (QURE) stock fell 48% after new Huntington's disease trial data missed the statistical bar in its AMT-130 gene therapy ...
Qure (QURE) stock plunges as new trial data for gene therapy candidate AMT-130 in Huntington’s disease disappoint investors.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results